Home > Healthcare > Pharmaceuticals > Finished Drug Form > Antidepressant Drugs Market

Antidepressant Drugs Market Share

Report ID: GMI2505
Published Date: Sep 2021
Report Format: PDF

Download Free Sample

Antidepressant Drugs Market Share

The global market consists of numerous companies including:

Eli Lilly & Company
N.V. Organon
Takeda Pharmaceuticals
Janssen Pharmaceuticals
Novartis AG
Opko Health
Pfizer
Bristol-Myers Squibb
GlaxoSmithKline
Patheon Inc
Sandoz Inc
Intra-Cellular Therapies
Otsuka Pharmaceutical
Zhejiang NHU Company Ltd
Sun Pharmaceuticals Pvt. Ltd

These leaders have undertaken several growth strategies such as partnerships, business expansion, acquisitions and product launches to increase their market position.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market size of antidepressant drugs was over USD 13.5 billion during 2020 and is expected to witness around 7.2% CAGR up to 2027 with increased access to a large number of products.

Serotonin-norepinephrine reuptake inhibitors (SNRIs) class of drugs held nearly 9% of global antidepressant drugs industry share in 2020 and will grow due to increasing cases of depression and anxiety disorders.

The key types of antidepressant drugs include Serotonin-norepinephrine Reuptake Inhibitors (SNRIs), Selective Serotonin Reuptake Inhibitors {SSRIs} and Tricyclic Antidepressants.

Europe market held more than 25% of revenue share in 2020 and will expand with rising awareness and acceptance of mental disorders and related therapies.

Leading antidepressant drug manufacturers worldwide include Novartis, GlaxoSmithKline, Pfizer, Eli Lilly & Company, Janssen Pharmaceuticals, Bristol-Myers Squibb, Sandoz Inc., Otsuka Pharmaceutical and Sun Pharmaceuticals, among some others.